OBM Neurobiology

(ISSN 2573-4407)

OBM Neurobiology is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc. By design, the scope of OBM Neurobiology is broad, so as to reflect the multidisciplinary nature of the field of Neurobiology that interfaces biology with the fundamental and clinical neurosciences. As such, OBM Neurobiology embraces rigorous multidisciplinary investigations into the form and function of neurons and glia that make up the nervous system, either individually or in ensemble, in health or disease. OBM Neurobiology welcomes original contributions that employ a combination of molecular, cellular, systems and behavioral approaches to report novel neuroanatomical, neuropharmacological, neurophysiological and neurobehavioral findings related to the following aspects of the nervous system: Signal Transduction and Neurotransmission; Neural Circuits and Systems Neurobiology; Nervous System Development and Aging; Neurobiology of Nervous System Diseases (e.g., Developmental Brain Disorders; Neurodegenerative Disorders).

OBM Neurobiology publishes a variety of article types (Original Research, Review, Communication, Opinion, Comment, Conference Report, Technical Note, Book Review, etc.). Although the OBM Neurobiology Editorial Board encourages authors to be succinct, there is no restriction on the length of the papers. Authors should present their results in as much detail as possible, as reviewers are encouraged to emphasize scientific rigor and reproducibility.

Publication Speed (median values for papers published in 2025): Submission to First Decision: 10.3 weeks; Submission to Acceptance: 17.1 weeks; Acceptance to Publication: 8.0 days (1-2 days of FREE language polishing included)

Special Issue

Neurobiology of Attention Deficit Hyperactivity Disorder: From Diagnosis to Treatment

Submission Deadline: July 31, 2027 (Open) Submit Now

Guest Editors

Fabrizio Stasolla, PhD ORCID logo

Professor, University “Giustino Fortunato” of Benevento, Benevento, Italy

Website1 | Website2 | E-Mail

Research Interests: ADHD; autism spectrum disorders; cerebral palsy; rare genetic syndromes (e.g. Angelman, Rett, Cornelia de Lange, fragile X); cognitive-behavioral interventions; post-coma; Alzheimer's disease; Parkinson's disease; sclerosis neurodegenerative diseases; single-subject experimental designs

Anna Passaro, PhD ORCID logo

Doctor in Learning Sciences and Digital Technologies, University “Giustino Fortunato” of Benevento, Benevento, Italy

Website1 | Website2 | E-Mail

Research Interests: Developmental and educational psychology; assistive and digital technologies for assessment, training, and rehabilitation; virtual, augmented, and mixed reality; serious games; executive functions, adaptive behavior, academic skills, and socio-emotional well-being in children and adolescents; autism spectrum disorder, ADHD, dyslexia, dyscalculia, intellectual disability, and rare genetic syndromes; personalized interventions, neurorehabilitation, and caregiver support

About This Topic

Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders evolving from e childhood, often continuing into adolescence, and still present in adulthood. Early diagnosis and individualized treatment are crucial for positive outcomes. Besides pharmacological interventions, behavioral approaches combined with cognitive rehabilitation are commonly applied, as well as neuropsychological assessment. Recently, new technologies and artificial intelligence-based solutions emerged as complementary options for both assessment and recovery purposes. The current special issue seeks to include empirical studies, case reports, and reviews focusing on the evaluation and treatment of ADHD, useful to outline helpful insights and tips for caregivers, families, practitioners, and teachers who deal daily with this specific neurodevelopmental disorder and its correlates. Topics may include, but are not limited to, diagnosis and interventions deriving from any theoretical approach, behavioral and cognitive interventions, technology-based rehabilitation programs, school-based interventions, parent training, teacher training, and multidisciplinary approaches aimed at promoting evidence-based and individualized practices for children and adolescents with ADHD.

Keywords

ADHD; neurobiology; pharmacological, and non-pharmacological interventions; inclusion; quality of life; technology

Manuscript Submission Information

Manuscripts should be submitted through the LIDSEN Submission System. Detailed information on manuscript preparation and submission is available in the Instructions for Authors. All submitted articles will be thoroughly refereed through a single-blind peer-review process and will be processed following the Editorial Process and Quality Control policy. Upon acceptance, the article will be immediately published in a regular issue of the journal and will be listed together on the special issue website, with a label that the article belongs to the Special Issue. LIDSEN distributes articles under the Creative Commons Attribution (CC BY 4.0) License in an open-access model. The authors own the copyright to the article, and the article can be free to access, distribute, and reuse provided that the original work is correctly cited.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). Research articles and review articles are highly invited. Authors are encouraged to send the tentative title and abstract of the planned paper to the Editorial Office (neurobiology@lidsen.com) for record. If you have any questions, please do not hesitate to contact the Editorial Office.

Welcome your submission!

Journal Metrics
2025
CiteScore SJR SNIP
1.80.2610.274
Newsletter

TOP